Cellect Biotechnology

$3.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-3.73%) As of 3:53 PM UTC today

Why Robinhood?

You can buy or sell APOP and other stocks, options, and ETFs commission-free!

About APOP

Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel. The listed name for APOP is Cellect Biotechnology Ltd. American Depositary Shares.

CEO
Shai Yarkoni
Employees
14
Headquarters
Kfar Saba, Jerusalem
Founded
1986
Market Cap
12.79M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
400.60K
High Today
$3.44
Low Today
$3.27
Open Price
$3.42
Volume
36.29K
52 Week High
$5.40
52 Week Low
$0.40

APOP Earnings

-$0.12
-$0.08
-$0.04
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Apr 5, Pre-Market

You May Also Like

INCY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure